由SPI1降低FARSB调节通过mTOR途径肺腺癌的进展和免疫微环境
Yiting Wang1, Yifan Zhou2, Shangwei Chen2
1Laboratory Medical, Guangxi Hospital Division of The First Affiliated Hospital, Sun Yat-sen University, Guangxi, China.
Journal of the Chinese Medical Association : JCMA
|September 3, 2025
概括
在肺腺癌 (LUAD) 中,转录因子SPI1抑制了氨酸-tRNA合成酶子单元β (FARSB). 这种抑制抑制了瘤的进展,并通过阻断mTOR途径增强了抗瘤免疫力.
科学领域:
- 癌症学
- 分子生物学
- 免疫学
背景情况:
- 氨酸-tRNA合成酶子单元β (FARSB) 与癌症的进展有关.
- 它在肺腺癌 (LUAD) 和瘤免疫微环境中的具体作用尚不清楚.
研究的目的:
- 研究FARSB在LUAD进展中的作用及其对免疫微环境的影响.
- 探索FARSB在LUAD中的监管机制.
主要方法:
- 对FARSB表达的生物信息学分析,通路丰富以及与预后和CD8+T细胞透的相关性.
- 通过使用qRT-PCR,西斑和功能测试,研究了SPI1对FARSB的转录抑制.
- 评估了LUAD细胞活力,增殖,细胞亡和CD8+ T细胞反应.
主要成果:
- 在LUAD组织和细胞中,FARSB的表达显著更高,与抑制的CD8+T细胞透相关.
- FARSB激活了mTOR通路,促进了LUAD细胞的生长和存活,并导致了CD8+ T细胞的消耗.
- SPI1被确定为FARSB的抑制剂,抑制LUAD的进展并增强抗瘤免疫力.
结论:
- SPI1通过转录抑制FARSB,从而抑制mTOR通路.
- 这种SPI1介导的FARSB降低抑制LUAD的进展,并促进CD8+T细胞的抗瘤免疫力.
更多相关视频
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
1.3K
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
1.7K
相关概念视频
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Interactions Between Signaling Pathways
6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
